Viewing Study NCT06350318


Ignite Creation Date: 2025-12-25 @ 4:54 AM
Ignite Modification Date: 2026-02-28 @ 7:09 PM
Study NCT ID: NCT06350318
Status: RECRUITING
Last Update Posted: 2025-11-03
First Post: 2024-04-01
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Rituximab and Zanubrutinib in Patients With Indolent B-cell Lymphomas
Sponsor: H. Lee Moffitt Cancer Center and Research Institute
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module